Envoy Medical, Inc.
COCH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -28.8% | 33.3% | -23.5% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -229.8% | -149.7% | -110.1% | -148.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -8,802.7% | -9,426.9% | -3,641.8% | -2,193.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9,242.2% | -9,469% | -6,718.6% | -2,798.4% |
| EPS Diluted | -1.49 | -2.54 | -1.57 | -1.05 |
| % Growth | 41.3% | -61.8% | -49.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |